NCT02788565View on ClinicalTrials.gov

Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine Tumours

CompletedOBSERVATIONAL
Enrollment

156

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

December 31, 2016

Conditions
Gastroenteropancreatic Neuroendocrine Tumours
Trial Locations (2)

22241

Skane University Hospital, Lund

75185

Uppsala University Hospital, Uppsala

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY